BillionToOne
BillionToOne builds molecular diagnostics that use quantitative molecular counting of cell-free DNA for prenatal screening and cancer testing. Its menu includes noninvasive prenatal tests (UNITY) and liquid-biopsy assays offered to clinicians and health systems through its clinical laboratories. Founded in 2016 and headquartered in Menlo Park, California, the company is publicly traded on Nasdaq.
Open Positions at BillionToOne
1 open position
Senior LIMS Engineer responsible for integrating clinical laboratory systems and owning critical sample-processing software for a high-throughput prenatal diagnostics lab. The role combines Python development, automation, infrastructure improvements, and regulated clinical software delivery.